🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The focus of this study is to test the safety and efficacy of the PCSK9 inh...
Status
Completed
Location
Stanford University
Start Date
2019-05-13
Trial ID
NCT03537742
Treatments Being Tested
Primary Objective: To evaluate the effect of alirocumab (SAR236553/REGN727...
Status
Completed
Location
Investigational Site Number 840616
Start Date
2011-01
Trial ID
NCT01288469
Treatments Being Tested
This is a phase IV, multi-center, double-blind, randomized, placebo- contro...
Status
Terminated
Location
San Francisco VA Medical Center
Start Date
2018-08-04
Trial ID
NCT03542110
Treatments Being Tested
The study is a prospective, open-label, randomized, single-center study inv...
Status
Completed
Location
Beijing Anzhen Hospital
Start Date
2019-03-02
Trial ID
NCT04851769
Treatments Being Tested
Primary Objective: To demonstrate the reduction of low-density lipoprotein...
Status
Completed
Location
Investigational Site Number 392028
Start Date
2015-11-30
Trial ID
NCT02584504
Treatments Being Tested
Alirocumab (SAR236553/REGN727) is a fully human monoclonal antibody that bi...
Status
Completed
Location
Investigational Site Number 840857
Start Date
2012-07
Trial ID
NCT01644175
Treatments Being Tested
The primary objective of the study was to assess the long-term safety and t...
Status
Completed
Location
Multiple Locations
Start Date
2012-02-28
Trial ID
NCT01576484
Treatments Being Tested
Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors increase LDL re...
Status
Unknown
Location
Eduard Ilgiyaev
Start Date
2019-01
Trial ID
NCT03634293
Treatments Being Tested
Primary Objective: To provide participants with severe hypercholesterolemi...
Status
Completed
Location
Investigational Site Number 040001
Start Date
2015-06-23
Trial ID
NCT02476006
Evaluation of adherence, persistence and efficacy of treatment with PCSK9 i...
Status
Recruiting
Location
Ospedali dell'Ovest Vicentino
Start Date
2020-03-07
Trial ID
NCT05430828
Treatments Being Tested